Tumor endothelial cells downregulate genes responsible for major histocompatibility complex (MHC) expression impeding their antigen-presenting functions, thus contributing to tumor immune evasion (Goveia et al., 2020). The gene discussed is HLA-C; the disease is neoplasm.